GENOCEA BIOSCIENCES INC - COM NEW (GNCA)

CUSIP: 372427401

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM NEW
Total 13F shares
33,922,302
Share change
+2,080,667
Total reported value
$79,378,000
Put/Call ratio
28%
Price per share
$2.34
Number of holders
44
Value change
+$4,702,574
Number of buys
21
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 372427401?
CUSIP 372427401 identifies GNCA - GENOCEA BIOSCIENCES INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENOCEA BIOSCIENCES INC - COM NEW (GNCA) as of Q2 2021

As of 30 Jun 2021, GENOCEA BIOSCIENCES INC - COM NEW (GNCA) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,922,302 shares. The largest 10 holders included NEA Management Company, LLC, Avoro Capital Advisors LLC, BVF INC/IL, COMMODORE CAPITAL LP, Point72 Asset Management, L.P., KINGDON CAPITAL MANAGEMENT, L.L.C., CITADEL ADVISORS LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, and ABG Innovation Capital Partners III GP Ltd. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.